Helios Finance, the company behind the specialized Bitcoin-native lending protocol and credit card, has raised $1M in funding to bridge the gap between long-termHelios Finance, the company behind the specialized Bitcoin-native lending protocol and credit card, has raised $1M in funding to bridge the gap between long-term

Helios Finance Secures $1M in Funding to Unlock On-Chain Bitcoin Liquidity

2026/03/06 22:00
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
Helios Finance Secures $1M in Funding to Unlock On-Chain Bitcoin Liquidity

Helios Finance, the company behind the specialized Bitcoin-native lending protocol and credit card, has raised $1M in funding to bridge the gap between long-term Bitcoin holding and real-world liquidity.

The round saw participation from top-tier venture firms including Draper Associates, Draper Dragon, 3Commas Capital, and the BitcoinFi Accelerator. A select group of strategic angel investors also joined the round to support the mission of bringing productive usecases to the world’s most secure network.

The funding will be used to scale Helios’s core infrastructure, which allows users to access real-world spending power without triggering the tax consequences or the long-term regret associated with selling BTC.

What is Helios Finance?

Unlike traditional wrapped-asset protocols that require users to move Bitcoin onto Ethereum or other chains, Helios focuses on maintaining a “Bitcoin-first” experience. The platform’s standout feature, built on the MIDL execution layer,  is a Bitcoin-backed credit card and lending suite that allows users to borrow against their holdings instantly.

The goal is to move Bitcoin away from being a “dormant” store of value and into a functional, programmable financial tool. Tim Draper, a prominent Silicon Valley venture capitalist who has also invested in SpaceX, Tesla and Coinbase, sees Helios as a critical piece of the puzzle for the next phase of adoption.

“Helios is transforming Bitcoin from a passive asset into a functional bank on-chain,” Draper noted. “With their lending platform and Bitcoin credit card, they’ve unlocked the liquidity of the world’s most secure asset. This is exactly how we transition to a Bitcoin economy.”

The Shift to BitcoinFi

The investment comes at a pivotal time for “BitcoinFi”, a growing sector dedicated to building decentralized finance (DeFi) capabilities directly on or around the Bitcoin network. As institutional interest in Bitcoin peaks, the demand for sophisticated credit products is skyrocketing.

“As the Bitcoin ecosystem matures, our mission is to turn dormant BTC into productive, programmable capital that still lives on-chain,” said Tristan Kleine-Fournier, Founder & CEO of Helios. “We’re building products that let Bitcoin holders tap into their Bitcoin wealth in everyday life, without ever having to sell the asset they trust more than fiat.”

Scaling the On-Chain Bank

While many lending platforms struggled during previous market cycles due to opaque rehypothecation, Helios is leaning into the transparency of on-chain collateralization. By offering a direct bridge to a credit card, the startup is positioning itself as the primary interface for users who want to live on a Bitcoin standard.

The Helios team plans to use the $1M injection to expand its engineering team and accelerate the rollout of its credit card to a global waitlist. As Bitcoin trends toward a global reserve asset, Helios is betting that the industry’s most vital service won’t be helping people sell their Bitcoin, it will be ensuring they never have to.

Secure your spot on the Helios Reserve Credit Card waitlist at www.heliosreserve.xyz

The Bitcoin economy is coming, don’t get left behind. Secure your spot on the Helios Reserve Credit Card waitlist at www.heliosreserve.xyz and be among the first to spend your Bitcoin without ever selling a single sat. 

About Helios Finance

Helios Finance is a Bitcoin-native lending and credit platform designed to unlock on-chain liquidity without requiring users to sell their BTC. Helios enables Bitcoin holders to borrow, spend, and earn in a fully on-chain, self-custodial environment. Its suite of products, including the Bitcoin-backed credit card, transforms Bitcoin from a dormant asset into a productive financial instrument for the emerging Bitcoin economy.

About Draper Associates

Draper Associates, founded in 1985 by Tim Draper, is a seed-stage venture capital firm that helps entrepreneurs drive their businesses to greatness. Tim Draper is one of Silicon Valley’s most prominent venture capitalists, investing in legendary companies such as SpaceX, Tesla and Coinbase. He is an ardent proponent of Bitcoin and is recognized as one of the world’s largest cryptocurrency holders.

About Draper Dragon

Draper Dragon, established in 2006 by Larry Li, Andy Tang, and Tim Draper, is a cross-border venture capital firm that bridges the gap between Silicon Valley and Asian innovation hubs. As a core member of the Draper Venture Network, the firm specializes in early-stage investments within the Web3, blockchain, and digital asset sectors. Draper Dragon has been a pivotal backer of transformative crypto infrastructure, with a portfolio that includes industry leaders such as Coinbase, Ledger, and Vechain.

The post Helios Finance Secures $1M in Funding to Unlock On-Chain Bitcoin Liquidity appeared first on Metaverse Post.

Market Opportunity
Belong Logo
Belong Price(LONG)
$0.001935
$0.001935$0.001935
-1.12%
USD
Belong (LONG) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09